Shanghai Blue Magpie Biomedical Co., Ltd. (abbreviated as "Blue Magpie Biomedical"), established in April 2019, is a new drug R&D company focusing on early innovative research of mRNA drugs. It has developed a one-step mRNA drug development platform covering mRNA synthesis, early discovery of new targets, and rapid expansion of product pipelines. We focus on mRNA vaccines and mRNA-based drug therapies for the treatment of severe diseases. The founder team comes from Harvard University, Yale University, and Karolinska Institute in Sweden. Blue Magpie Biomedical has laboratories in Jiangwan, Shanghai and Houston, USA.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows